Efficacy and influence factors of concurrent radiotherapy and chemotherapy for high-grade brainstem glioma
10.3969/j.issn.1000-8179.2019.18.738
- VernacularTitle:高级别脑干胶质瘤同步放化疗疗效及影响因素
- Author:
Xun KANG
1
;
Zehao CAI
;
Shoubo YANG
;
Wenbin LI
Author Information
1. 首都医科大学附属北京天坛医院神经外科神经肿瘤综合治疗病区
- Keywords:
brainstem glioma;
radiotherapy;
temozolamide;
prognosis
- From:
Chinese Journal of Clinical Oncology
2019;46(18):930-933
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To perform a retrospective analysis of the prognosis and influence factors of radiotherapy concurrent with che-motherapy and adjuvant temozolomide therapy in adult patients with high-grade brainstem glioma. Methods: Twenty-nine patients with pathological diagnosis of high-grade glioma (World Health Organization [WHO] Ⅲ and Ⅳ) from June 2012 to December 2013 were eligible for inclusion in the analysis. Demographic and clinical characteristics including age, gender, the time from morbidity to operation, the size of the lesion, the method of operation, the Karnofsky Performance Status (KPS) score, and the pathological grade were examined. The significance of related prognostic factors was evaluated via univariate and multivariate Logistic regression analy-sis. A P-value of<0.05 was considered to be statistically significant. Results: The median overall survival (OS) was 11.5 months. Univari-ate analysis showed that low WHO grade index was associated with better outcome (P<0.05). Multivariate analysis suggested that high KPS score (>60) and low WHO grade were associated with better survival. Conclusions: In this study, low pathological grade and high KPS score were independently associated with better survival among patients with high-grade brainstem glioma.
